Chemical structure:

IUPAC name:

8-bromo-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-yl methyl)-3,7-dihydro-purine-2,6- dione

CAS number:

8353029-57-9

Therapy area:

Anti-Diabetic

Final API name:

Linagliptin

Manufacturing status:

Under development